Thymoma: Update for the new millenium

Scott B. Johnson, Tony Y. Eng, Giuseppe Giaccone, Charles Thomas

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Thymomas are relatively common tumors of the anterior superior mediastinum. They are usually relatively slowly growing tumors and their prognosis depends on the macroscopic and microscopic invasion of surrounding tissues. Surgery is the mainstay treatment of thymomas, and complete resection represents one of the most important prognostic factors in this disease. Other important prognostic indicators include the tumor stage and size and the presence of symptoms. Postoperative radiotherapy is indicated in tumors with invasion of surrounding tissues, even if resection was radical, since it improves local control and survival. Cytotoxic chemotherapy has been employed in several relatively small phase II studies and in advanced disease has been demonstrated to produce a 50%-80% objective response rate. Neoadjuvant cytotoxic chemotherapy and/or external beam radiotherapy has been used with some success in patients with tumors which are not readily resectable. Novel antiproliferative systemic agents, with both cytotoxic and cytostatic mechanisms of action, are being tested in ongoing prospective clinical trials.

Original languageEnglish (US)
Pages (from-to)239-246
Number of pages8
JournalOncologist
Volume6
Issue number3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Thymoma
Neoplasms
Radiotherapy
Drug Therapy
Mediastinum
Cytostatic Agents
Clinical Trials
Survival

Keywords

  • Myasthenia gravis
  • Thymoma
  • Tumor stage

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Thymoma : Update for the new millenium. / Johnson, Scott B.; Eng, Tony Y.; Giaccone, Giuseppe; Thomas, Charles.

In: Oncologist, Vol. 6, No. 3, 2001, p. 239-246.

Research output: Contribution to journalArticle

Johnson, SB, Eng, TY, Giaccone, G & Thomas, C 2001, 'Thymoma: Update for the new millenium', Oncologist, vol. 6, no. 3, pp. 239-246. https://doi.org/10.1634/theoncologist.6-3-239
Johnson, Scott B. ; Eng, Tony Y. ; Giaccone, Giuseppe ; Thomas, Charles. / Thymoma : Update for the new millenium. In: Oncologist. 2001 ; Vol. 6, No. 3. pp. 239-246.
@article{c48782c2888746998035544014d71355,
title = "Thymoma: Update for the new millenium",
abstract = "Thymomas are relatively common tumors of the anterior superior mediastinum. They are usually relatively slowly growing tumors and their prognosis depends on the macroscopic and microscopic invasion of surrounding tissues. Surgery is the mainstay treatment of thymomas, and complete resection represents one of the most important prognostic factors in this disease. Other important prognostic indicators include the tumor stage and size and the presence of symptoms. Postoperative radiotherapy is indicated in tumors with invasion of surrounding tissues, even if resection was radical, since it improves local control and survival. Cytotoxic chemotherapy has been employed in several relatively small phase II studies and in advanced disease has been demonstrated to produce a 50{\%}-80{\%} objective response rate. Neoadjuvant cytotoxic chemotherapy and/or external beam radiotherapy has been used with some success in patients with tumors which are not readily resectable. Novel antiproliferative systemic agents, with both cytotoxic and cytostatic mechanisms of action, are being tested in ongoing prospective clinical trials.",
keywords = "Myasthenia gravis, Thymoma, Tumor stage",
author = "Johnson, {Scott B.} and Eng, {Tony Y.} and Giuseppe Giaccone and Charles Thomas",
year = "2001",
doi = "10.1634/theoncologist.6-3-239",
language = "English (US)",
volume = "6",
pages = "239--246",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "3",

}

TY - JOUR

T1 - Thymoma

T2 - Update for the new millenium

AU - Johnson, Scott B.

AU - Eng, Tony Y.

AU - Giaccone, Giuseppe

AU - Thomas, Charles

PY - 2001

Y1 - 2001

N2 - Thymomas are relatively common tumors of the anterior superior mediastinum. They are usually relatively slowly growing tumors and their prognosis depends on the macroscopic and microscopic invasion of surrounding tissues. Surgery is the mainstay treatment of thymomas, and complete resection represents one of the most important prognostic factors in this disease. Other important prognostic indicators include the tumor stage and size and the presence of symptoms. Postoperative radiotherapy is indicated in tumors with invasion of surrounding tissues, even if resection was radical, since it improves local control and survival. Cytotoxic chemotherapy has been employed in several relatively small phase II studies and in advanced disease has been demonstrated to produce a 50%-80% objective response rate. Neoadjuvant cytotoxic chemotherapy and/or external beam radiotherapy has been used with some success in patients with tumors which are not readily resectable. Novel antiproliferative systemic agents, with both cytotoxic and cytostatic mechanisms of action, are being tested in ongoing prospective clinical trials.

AB - Thymomas are relatively common tumors of the anterior superior mediastinum. They are usually relatively slowly growing tumors and their prognosis depends on the macroscopic and microscopic invasion of surrounding tissues. Surgery is the mainstay treatment of thymomas, and complete resection represents one of the most important prognostic factors in this disease. Other important prognostic indicators include the tumor stage and size and the presence of symptoms. Postoperative radiotherapy is indicated in tumors with invasion of surrounding tissues, even if resection was radical, since it improves local control and survival. Cytotoxic chemotherapy has been employed in several relatively small phase II studies and in advanced disease has been demonstrated to produce a 50%-80% objective response rate. Neoadjuvant cytotoxic chemotherapy and/or external beam radiotherapy has been used with some success in patients with tumors which are not readily resectable. Novel antiproliferative systemic agents, with both cytotoxic and cytostatic mechanisms of action, are being tested in ongoing prospective clinical trials.

KW - Myasthenia gravis

KW - Thymoma

KW - Tumor stage

UR - http://www.scopus.com/inward/record.url?scp=0034960006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034960006&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.6-3-239

DO - 10.1634/theoncologist.6-3-239

M3 - Article

C2 - 11423670

AN - SCOPUS:0034960006

VL - 6

SP - 239

EP - 246

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 3

ER -